News
Dapagliflozin plus methylcobalamin improved nerve function and glucose control in diabetic neuropathy.
In last two decades, the country’s IP model continues to serve as a global benchmark for balancing innovation with public ...
Q: I live in a retirement community and have noticed that while some neighbors seem to have mild trouble with remembering ...
People with type 1 diabetes require insulin therapy for life, but the side effects can include weight gain and chronic kidney ...
A clinical trial involving adolescents with type 1 diabetes (T1D) has found a combination therapy may reduce chronic kidney ...
A clinical trial involving adolescents with type 1 diabetes (T1D) has found a combination therapy may reduce chronic kidney ...
The Subject Expert Committee (SEC) for Endocrinology & Metabolism under the Central Drugs Standard Control Organisation ...
Q: I’m achy and tired a lot and my doctor said it comes from chronic inflammation. What is that exactly and how can I get it ...
Originally designed as glucose-lowering medications, SGLT2 inhibitors provide benefits across the cardio-renal-metabolic ...
Patients will be able to register for clinical trials via the NHS App under new Government plans to speed up access to new ...
Learn how SGLT2 inhibitor dapagliflozin improves MASH outcomes, with potential clinical use beyond diabetes care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results